Tag: Available

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

  • Neftaly To ensure available medicines are safe, efficacious and of high quality (HSS)

    Neftaly To ensure available medicines are safe, efficacious and of high quality (HSS)

    Neftaly: Ensuring the Safety, Efficacy, and Quality of Medicines

    Overview

    Access to safe, effective, and high-quality medicines is essential for the successful treatment of diseases and for building public trust in the healthcare system. However, the circulation of substandard, counterfeit, or improperly stored medications remains a significant threat in many settings. Neftaly is committed to supporting national efforts to strengthen pharmaceutical systems and regulatory frameworks to ensure that all medicines available to the public meet stringent safety, efficacy, and quality standards.


    Goal

    To establish and support robust systems and practices that guarantee all medicines available within the health system are safe, efficacious, and of assured quality, in alignment with national and international standards.


    Strategic Objectives

    1. Strengthen Regulatory Oversight

    • Support the capacity-building of national medicines regulatory authorities (NMRAs) to enforce quality assurance standards throughout the pharmaceutical supply chain.
    • Promote alignment with WHO prequalification and internationally accepted Good Manufacturing Practices (GMP), Good Distribution Practices (GDP), and Good Pharmacy Practices (GPP).
    • Strengthen systems for registration, inspection, and post-marketing surveillance of pharmaceutical products.

    2. Improve Quality Control and Pharmacovigilance

    • Enhance laboratory infrastructure and technical capacity for quality control testing of medicines, including random sampling and batch testing.
    • Establish or strengthen pharmacovigilance systems to detect, report, and respond to adverse drug reactions (ADRs) and product quality issues.
    • Promote training for healthcare workers, pharmacists, and community health actors in recognizing and reporting medicine-related problems.

    3. Ensure Safe Procurement and Supply Chain Management

    • Support transparent and evidence-based procurement practices that prioritize quality-assured and cost-effective medicines.
    • Strengthen supply chain systems to maintain integrity from manufacturer to end-user, including appropriate storage, transport, and stock management.
    • Promote regular audits and assessments to ensure medicines are not expired, compromised, or diverted.

    4. Increase Public Awareness and Accountability

    • Educate the public and health professionals on the importance of medicine quality and how to identify and report suspected substandard or falsified products.
    • Facilitate collaboration with civil society organizations to promote medicine safety at the community level.
    • Encourage the use of authentication tools and technology (e.g., SMS verification codes) to help verify medicine authenticity.

    5. Foster Regional and Global Partnerships

    • Collaborate with international partners and regulatory networks to share data, technical expertise, and early warning alerts on medicine quality risks.
    • Participate in joint regulatory reviews and harmonization initiatives to enhance efficiency and consistency in medicine oversight.
    • Promote pooled procurement mechanisms that prioritize quality and affordability.

    Expected Outcomes

    • Improved availability of medicines that are safe, effective, and of verified quality throughout the health system.
    • Reduced incidence of adverse drug reactions and treatment failures due to poor-quality medicines.
    • Increased public confidence in healthcare and medicine safety.
    • Strengthened national regulatory systems with sustainable capacity to monitor, inspect, and enforce standards.
    • A more resilient and transparent pharmaceutical supply chain.

    Conclusion

    Neftaly’s commitment to ensuring that all medicines are safe, efficacious, and high-quality is central to protecting public health and enhancing the credibility of national health systems. By supporting strong regulatory frameworks, quality control measures, and community engagement, we help create a healthcare environment where patients can trust in the treatment they receive.

  • Neftaly Strengthen the NTCP’s management and monitoring capacities, so that at least 95 percent of planned program activities under the grant, and for which funding is available in the country, are completed in 2017.

    Neftaly Strengthen the NTCP’s management and monitoring capacities, so that at least 95 percent of planned program activities under the grant, and for which funding is available in the country, are completed in 2017.

    Neftaly: Strengthening NTCP’s Management and Monitoring Capacities to Maximize Program Implementation

    A well-managed and effectively monitored National Tuberculosis Control Programme (NTCP) is critical to achieving national TB targets and ensuring the efficient use of available resources. Recognizing this, Neftaly (South African Youth Project) supported the NTCP in strengthening its management and monitoring systems to ensure successful execution of planned activities under donor-funded grants.


    Program Objective

    To strengthen the management and monitoring capacities of the NTCP so that at least 95% of planned program activities, with available funding, were fully implemented by the end of 2017.


    Strategic Focus Areas

    1. Program Management Enhancement

    • Provided technical support for workplan development, activity scheduling, and tracking against targets.
    • Strengthened internal coordination and oversight structures within NTCP to improve implementation efficiency.

    2. Grant Monitoring and Compliance

    • Supported NTCP to establish systems to track grant utilization, milestones, and deliverables.
    • Ensured that program managers had real-time access to budgetary and operational performance data.

    3. Capacity Building

    • Trained NTCP teams in project and financial management, grant compliance, and activity-based budgeting.
    • Developed and disseminated standard operating procedures (SOPs) for planning, execution, and reporting.

    4. Monitoring and Reporting Systems

    • Improved data collection and reporting tools to monitor implementation progress across all program components.
    • Conducted monthly and quarterly program reviews to identify delays, bottlenecks, and corrective actions.

    Key Results Achieved

    • Over 95% of planned and funded activities under the TB control grant were successfully implemented in 2017.
    • Significant improvements in program efficiency, accountability, and documentation.
    • Strengthened NTCP capacity to manage large-scale grants from donors such as the Global Fund and USAID.
    • Increased alignment of financial resources with strategic program priorities, reducing under-utilization of funds.

    Why This Matters

    High grant performance ensures that critical TB prevention, diagnosis, and treatment services reach the people who need them most. By supporting the NTCP to improve its management and monitoring systems, Neftaly helped safeguard investments, enhance service delivery, and advance national TB targets.


    Neftaly’s Commitment

    Neftaly continues to support national programs like NTCP in building resilient, results-driven systems that translate funding into tangible, measurable health outcomes.